EVO100

Product Evofem Biosciences, Inc.
Total Payments
$77,645
Transactions
18
Doctors
0
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $77,645 18 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $77,645 18 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
EVO100-311 840-405 Evofem Biosciences, Inc. $38,639 0
EVO100-311 840-427 Evofem Biosciences, Inc. $8,550 0
EVO100-311 840-404 Evofem Biosciences, Inc. $8,328 0
EVO100-311 840-411 Evofem Biosciences, Inc. $7,353 0
EVO100-311 840-430 Evofem Biosciences, Inc. $6,275 0
EVO100-311 840-413 Evofem Biosciences, Inc. $5,000 0
EVO100-311 840-408 Evofem Biosciences, Inc. $3,500 0

Top Doctors Receiving Payments for EVO100

Doctor Specialty Location Total Records
Unknown North Miami, FL $77,645 18

About EVO100

EVO100 is a product associated with $77,645 in payments to 0 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is Evofem Biosciences, Inc..

Payment data is available from 2020 to 2020. In 2020, $77,645 was paid across 18 transactions to 0 doctors.

The most common payment nature for EVO100 is "Unspecified" ($77,645, 100.0% of total).

EVO100 is associated with 7 research studies, including "EVO100-311 840-405" ($38,639).